A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

Clinical trial NCT06561685 · RECRUITING

Trial details

NCT number: NCT06561685
Sponsor: Eli Lilly and Company
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Solid Tumor Advanced Solid Tumor Non-small Cell Lung Cancer SMARCA4-Deficient Tumor

Start date: 2024-09-19
Primary completion: 2027-10-01
Enrollment: 340

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.